IDEXX LABORATORIES INC /DE
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.3 | $3.9 | $3.7 | $3.4 | $3.2 |
| Operating income | $1.4 | $1.1 | $1.1 | $0.9 | $0.9 |
| Net income | $1.1 | $0.9 | $0.8 | $0.7 | $0.7 |
| Cash Flow Statement | |||||
| Free cash flow | $1.1 | $0.8 | $0.8 | $0.4 | $0.6 |
| Share repurchases | $1.2 | $0.8 | $0.1 | $0.8 | $0.7 |
Shares outstanding 78.8M · Free float 99.2%
Annual filing data through FY ended December 31, 2025; float as of September 21, 2026.